AQR Capital Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,361
| Closed | -$406K | – | 2338 |
|
|
2021
Q3 | $406K | Sell |
2,361
-2,012
| -46% | -$346K | ﹤0.01% | 1939 |
|
|
2021
Q2 | $539K | Sell |
4,373
-10,050
| -70% | -$1.24M | ﹤0.01% | 1868 |
|
|
2021
Q1 | $1.96M | Buy |
14,423
+1,736
| +14% | +$235K | ﹤0.01% | 1217 |
|
|
2020
Q4 | $1.59M | Buy |
12,687
+9,291
| +274% | +$1.17M | ﹤0.01% | 1286 |
|
|
2020
Q3 | $382K | Sell |
3,396
-27,853
| -89% | -$3.13M | ﹤0.01% | 1830 |
|
|
2020
Q2 | $2.98M | Buy |
31,249
+4,431
| +17% | +$422K | ﹤0.01% | 987 |
|
|
2020
Q1 | $2.41M | Buy |
26,818
+21,818
| +436% | +$1.96M | ﹤0.01% | 1006 |
|
|
2019
Q4 | $265K | Buy |
+5,000
| New | +$265K | ﹤0.01% | 1939 |
|
|
2019
Q1 | – | Sell |
-9,255
| Closed | -$403K | – | 2249 |
|
|
2018
Q4 | $403K | Buy |
9,255
+2,155
| +30% | +$93.8K | ﹤0.01% | 1860 |
|
|
2018
Q3 | $406K | Sell |
7,100
-4,639
| -40% | -$265K | ﹤0.01% | 2016 |
|
|
2018
Q2 | $570K | Buy |
11,739
+2,202
| +23% | +$107K | ﹤0.01% | 1934 |
|
|
2018
Q1 | $373K | Buy |
+9,537
| New | +$373K | ﹤0.01% | 2001 |
|
|
2017
Q1 | – | Sell |
-18,568
| Closed | -$474K | – | 2277 |
|
|
2016
Q4 | $474K | Sell |
18,568
-1,859
| -9% | -$47.5K | ﹤0.01% | 1950 |
|
|
2016
Q3 | $739K | Buy |
+20,427
| New | +$739K | ﹤0.01% | 1827 |
|
|
2015
Q3 | – | Sell |
-6,700
| Closed | -$212K | – | 2293 |
|
|
2015
Q2 | $212K | Hold |
6,700
| – | – | ﹤0.01% | 2095 |
|
|
2015
Q1 | $255K | Sell |
6,700
-12,200
| -65% | -$464K | ﹤0.01% | 1941 |
|
|
2014
Q4 | $736K | Buy |
+18,900
| New | +$736K | ﹤0.01% | 1790 |
|
|
2014
Q2 | – | Sell |
-105,000
| Closed | -$3.62M | – | 2608 |
|
|
2014
Q1 | $3.62M | Buy |
+105,000
| New | +$3.62M | 0.01% | 989 |
|